The Silver Inks and Pastes Market - 2013: Researchmoz.us

ResearchMoz.us include new market research report"The Silver Inks and Pastes Market - 2013" to its huge collection of research reports.

This latest report from NanoMarkets quantifies the market opportunities for silver inks and pastes in electronics applications over the next eight years. In the report, we consider how the industry’s latest commercial strategies and technical developments, as well as the persistent environment of high silver prices, which has been in effect for over 18 months now, have affected the market for printed silver in electronics. We identify the applications in which printed silver will generate revenue for the industry in the near- and mid-term, and we examine the key players in the silver inks/pastes markets. The report provides granular, eight-year volume and revenue forecasts for this business by application and by material.

Printed silver, with its superior conductivity, stability, and ease-of-use in printing applications, has long held a critical place in electronics applications, and suppliers of printable silver materials have enjoyed a fortunate history of new applications – home electronics, computers and displays, photovoltaics, etc. – for their materials. In the report, we consider the following, shifting, opportunities for silver inks and pastes:

We examine the traditional electronics applications for printed silver – circuit boards, membrane switches, resistive heaters, keyboards, etc. – and look for opportunities for thick-film silver pastes to continue to make money.
We review the changes in the photovoltaics industry and discuss how changes in the business environment are damaging the growth of printed silver in this sector.
We look for rising applications – in OLEDs, in other new kinds of displays, and in sensors for pervasive electronics – that may be able to make up for losses elsewhere.
Finally, we consider whether the nanosilver revolution will ever happen, or if it is time to give up on nanosilver-based electronics.

Applications for printed silver covered by this report include: thick-film electronics (printed circuit boards, membrane switches, keyboards, resistive heaters, discrete electronic components, and other printed circuitry applications), displays (plasma and other displays), OLEDs (both lighting and displays), PV, sensors, and RFIDs.

NanoMarkets has been covering this sector now for more than six years, and this is latest in our ongoing series of industry analysis on silver materials used in various applications.

To know more about this reports, please visit @ http://www.researchmoz.us/the-silver-inks-and-pastes-market-2013-report.html

For All Latest Reports Kindly Visit @ http://www.researchmoz.us/report.html

Contact: sales@researchmoz.us for further information.

Global and China Wiring Harness Industry Report, 2012: Researchmoz.us

ResearchMoz.us include new market research report " Global and China Wiring Harness Industry Report, 2012" to its huge collection of research reports.

The global automotive wiring harness market size was USD 24.3 billion in 2009, and rebounded strongly in 2010, especially in China. In addition, the soaring copper price has also expanded the market size, to USD 31.6 billion in 2010, up 29.9% year on year. In 2011, the copper price continued to rise, and the application of automotive electronics also increased the market size of wiring harness. 

In 2012, driven by the demand from North America, Japan and xEV market, the wiring harness market scaled USD 40.1 billion, a year-on-year growth of 9.7%. Its expected that the market growth will slow down in 2013, and the copper price will also fall slightly.

Japanese manufacturers are big winners in the automotive wiring harness market in 2012, while American and European manufacturers lag far behind. The gap between the No.1 Yazaki and No.2 Sumitomo Electric has increased. Yazaki acquired a Russian wiring harness enterprise in mid 2012, and made Tata Yazaki Autocomp as its wholly owned subsidiary in November 2012 by acquiring 50% stake held by Tata.

Due to the devotion to the Asia-Pacific market, Delphi lost its North America market, which was seized by Japanese enterprises. As the North America market performed much better than the Asia-Pacific market (especially the Chinese mainland market), thus Delphi suffered a rare decline. However, Delphi performed well in the Chinese mainland market and further consolidated its championship in the Chinese mainland market. Lear encountered the same situation, but the performance basically remained flat with a year earlier.

Japanese manufacturers have benefited from the recovery of the Japanese market. The market base in 2011 was low due to the impact from the earthquake, and rebounded strongly in 2012. The annual output in 2012 is expected to grow by 18% year on year, the highest in the world. 


Find newly published Market Research Reports @ Global and China Wiring Harness Industry

Small plants in Europe are underperforming, primarily due to the economic downturn in Europe. Chinese mainland enterprises have also witnessed decline for two consecutive years due to the decreasing sales volume of domestic automobile. Benefitting from the commercial vehicle market outburst in USA and the acquisition of AEES in 2011, PKC has improved its performance significantly. The performance of small and medium-sized manufacturers has declined significantly subjected to the continuous suppression from large manufacturers. 

Since 2011, Chinas automotive wiring harness industry has been migrating towards the inland, and most companies have transferred capacity to Chengdu, Chongqing and Wuhan. Delphi set up Chengdu base in June 2011, which was officially put into production in September 2012; it started the construction of Chongqing base in October 2012, which is expected to be put into production in June 2013. Yazaki set up a base in Xiaogan, Hubei in June 2011, which started commission in May 2012. LEONI completed the acquisition of Daekyeung at the end of 2011, obtaining the latters three production bases in Jining, Penglai and Qingdao. Lears Wuhan base set up Chongqing branch in 2003, which delivered remarkable performance in 2012 and increased the revenue of Lear Wuhan by nearly 50%. South Korean Yura started the construction of bases in Baoding of Hebei and Heze of Shandong in 2011, which started production in 2012. 

In 2012, Yazaki bases in China grew rapidly, especially the Yantai and Zhangzhou bases. Yantai Yazaki is mainly engaged in export business, and its annual revenue is expected to increase from RMB 1,252 million in 2011 to RMB 2,210 million. The revenue of Zhangzhou Yazaki is expected to increase from RMB 403 million in 2011 to RMB 750 million.

Find newly published Market Research Reports @  http://www.researchmoz.us/report.html

Contact: sales@researchmoz.us for further information.

Global and China Glass Fiber Industry Report, 2012-2015: Researchmoz.us

ResearchMoz.us include new market research report " Global and China Glass Fiber Industry Report, 2012-2015 " to its huge collection of research reports.

In 2011, the global glass fiber supply hit 4.88 million tons, and the demand reached 4.66 million tons. Driven by the demand in emerging markets, the global supply is expected to grow by more than 8% to 5.30 million tons, and demand will amount to 4.94 million tons at a growth rate of 6% in 2012.

With the transfer of the industry, China has become the world's largest producer of glass fiber. In 2011, China produced 3.72 million tons of glass fiber, accounting for 76% of the global total. China's glass fiber output will grow to 4.30 million tons in 2012, sharing 81% of the global output. As 16 Chinese fiberglass kilns enter the cold repair period as well as the backward capacity is eliminated, China's glass fiber capacity will reduce by 250,000 tons or so in 2013. With the new realization of new capacity and the rebounding of downstream demand, the prouduction will resume its growth during 2014-2015.

Like the global glass fiber industry, Chinese glass fiber market is also featured with high concentration, most of the capacity is concentrated in China Fiberglass Co., Ltd., Chongqing Polycomp International Corporation and Taishan Fiberglass Inc.. In 2012, these three companies altogether contribute 43% to the total glass fiber capacity in China. As the new capacity puts into production, it is expected that the capacity of the three companies will account for 49% of China's glass fiber capacity in 2015.

For More Information, Kindly Visit Us@ Global and China Glass Fiber Industry

China Fiberglass Co., Ltd. is the largest glass fiber manufacturer in China, with main products including twistless roving, chopped strand and electronic-grade glass fiber yarn. To avoid the anti-dumping policies of other countries against China, China Fiberglass has expanded its operations in overseas markets and successively established companies in Singapore, France, Japan, South Africa and other nations since 2010. In January 2012, China Fiberglass made investment for construction of an alkali-free glass fiber wiredrawing production line in Egypt; in October 2012, it built a 100,000 t/a alkali-free glass fiber wiredrawing production line in the United States. The foreign market layout helps China Fiberglass evade trade protectionism and raise overseas market share.

Taishan Fiberglass Inc, as the third largest glass fiber enterprise in China, has the similar product line to China Fiberglass, and it focuses on twistless roving and electronic-grade textile yarn. However, unlike China Fiberglass, Taishan Fiberglass enhances its exploration of domestic Chinese market, especially emerging application fields. In April 2012, Taishan Fiberglass obtained the S-1 HM high-performance glass twistless roving capacity of US-based AGY. Such twistless roving is mainly used for wind power generation. In the arena of wind power, Taishan Fiberglass has such regular customers as Sinomatech Wind Power Blade Co. Ltd., Lianyungang Zhongfu Lianzhong Composites Group, etc..

The report covers the followings:

• Global glass fiber supply and demand, competition pattern, and forecast for 2013-2015;
• Chinas glass fiber supply and demand, competition pattern, import and export, as well as forecast for 2013-2015;
• Development of glass fiber products in China, as well as competitive landscape of major market segments;
• Development of Chinese glass fiber downstream market, demand for glass fiber in 2011-2015;
• Development, capacity construction and development strategy of major glass fiber manufacturers in China and beyond.

Find newly published Market Research Reports @ http://www.researchmoz.us/report.html

Contact: sales@researchmoz.us for further information.

China Heparin Industry Report, 2012-2014: Researchmoz.us

ResearchMoz.us include new market research report "China Heparin Industry Report, 2012-2014" to its huge collection of research reports.

China, abundant in heparin raw materials, has become one of the worlds largest heparin API producers and exporters, owning to the quality of heparin API having won international recognition gradually. Due to the euro debt crisis, the global market suffered a deep recession. Coupled that the heparin export standard has lifted, Chinas export volume of heparin API was no more than 105.2 tons in 2011, approximating 14.6 trillion units (measured by 140IU/mg), with the proportion of around 45.9% in the global demand during the same period.

Leading heparin API suppliers worldwide include Shenzhen Hepalink Pharmaceutical, Changzhou Qianhong Bio-Pharma, Yantai Dongcheng Biochemicals and Nanjing King-Friend Biochemical Pharmaceutical, which have ranked top 4 industrial players by export for several years in a row, with the combined export value making up more than 70% of Chinas total export value of heparin. There is no distinct change in terms of the export pattern. However, the export prices of Chinas top 10 heparin exporters witnessed a downward mobility in 2011-2012H1. Nevertheless, it was not the same case for Dongying Tiandong Pharmaceutical and Jiangsu Medicine Health Care Article Imp. & Exp. (Group), whose export prices increased by 3.8% and 2.1% year-on-year respectively in Jan.-May, 2012, due to the improved quality of exported products as well as the low cardinal number of exported prices in the preceding year. 

To know more about this reports, please visit @ China Heparin Industry Market
 
Meanwhile, Chinese heparin API flagship enterprises including Shenzhen Hepalink Pharmaceutical, Changzhou Qianhong Bio-Pharma, Yantai Dongcheng Biochemicals, Hebei Changshan Biochemical Pharmaceutical and Nanjing King-Friend Biochemical Pharmaceutical are projected to expand their capacities and improve the heparin industry chains. Among these tycoons, the first four ones have made IPO, while Nanjing King-Friend Biochemical Pharmaceutical is also preparing for IPO by accepting tutoring. According to public information issued by related enterprises, the heparin API capacity of China will increase by more than 18 trillion units by 2014, with the total capacity expected to exceed 30 trillion units, making up over 70% of the global demand. 

Although China is a large country with rich heparin API, the downstream production of general heparin preparation and low molecular weight heparin preparation is still at the initial stage. In the high-end low molecular weight heparin preparation market, especially, joint ventures and foreign brands including Sanofi-Aventis, Pfizer and GSK have eroded into the Chinese market. According to China Pharmaceutical Industry Association, imported low molecular weight heparin calcium accounted for more than 60% of the total procurement of such products of representative hospitals in 22 Chinese cities in 2011. 

However, with the improvement of R&D and technological strength, the competitiveness of made-in-China low molecular weight heparin preparation market is increasingly enhancing. A case in point is Hebei Changshan Biochemical Pharmaceutical Co., Ltd, the capacity of low molecular weight heparin calcium injection of which soared from 4 million pcs to 10 million pcs in 2011, with the sales increased by 68.4% year-on-year to RMB86.93 million, compared to the sales of RMB117 million in 2012H1, a year-on-year rise of 237.6%.

Find newly published Market Research Reports @  http://www.researchmoz.us/report.html

Contact: sales@researchmoz.us for further information.

China Prestressed Concrete Cylinder Pipe (PCCP) Industry Report, 2012-2014: Researchmoz.us

ResearchMoz.us include new market research report " China Prestressed Concrete Cylinder Pipe (PCCP) Industry Report, 2012-2014 " to its huge collection of research reports.

After 20 years of development, there have been a number of concrete aqueduct enterprises engaged in the production and sales of prestressed concrete cylinder pipe (PCCP) in China, more than 60 of which have a designed annual capacity of more than 3,000 km respectively, and top eight of which occupy about 70% of the market collectively. Large enterprises of the industry primarily supply nationwide water conservancy projects, while smaller enterprises mainly supply local ones. 

To know more about this reports, please visit @ China Prestressed Concrete Cylinder Pipe Market

Chinas PCCP industry has great development potential. On the one hand, the application of PCCP in the field of key water resource engineering such as water supply engineering and farmland irrigation is only 20% in China, a large distance from about 60% in developed countries; on the other hand, the accelerated investment in water conservancy construction by the Chinese government is also an important factor driving rapid development of Chinas PCCP industry. 

China Prestressed Concrete Cylinder Pipe (PCCP) Industry Report, 2012-2014 contains six chapters (mainly including the industry overview, competitive landscape and market forecasts), 66 charts, and an introduction of 11 enterprises (mainly including the company profile, financial data, capacity and major projects). In addition, the report not only introduces the development of PCCP in China, but also analyzes the driving force and other factors that affect Chinas PCCP industry.

Find newly published Market Research Reports @ http://www.researchmoz.us/report.html

Contact: sales@researchmoz.us for further information.

China Fluorine Chemical Industry Chain Report, 2012-2015: Researchmoz.us

ResearchMoz.us include new market research report "China Fluorine Chemical Industry Chain Report, 2012-2015 " to its huge collection of research reports.

Fluorine chemical industry treats fluorite as main raw material, with downstream products embracing inorganic fluoride and organic fluoride. 

Chinas recoverable reserves of fluorite merely accounts for about one-tenth of the world total, but the output occupies the first position with a proportion of more than 50%. Since 2010, China has tightened control over fluorite mining exploration, causing a slight decrease in output, down to 2.9 million tons in 2011. In China, the distribution of fluorite production is relatively concentrated, Hunan, Zhejiang, Inner Mongolia, Jiangxi, Yunnan and Fujian provinces (or autonomous regions) contribute an approximate 85%. 

Inorganic fluoride sub-industries mainly refer to hydrofluoric acid, aluminum fluoride, electric grade fluoride, and so on. 

For now, hydrofluoric acid and aluminum fluoride industries in China have stepped into advanced development stage, with excess supply; in future, adjustment of product structure will be the focus, whereupon, backward production capacity will be gradually phased out. In 2011, Chinas total capacity of hydrofluoric acid reached 1.645 million tons, major manufacturers include Dongyue Group Ltd., Yingpeng Chemicals Co., Ltd., Do-Fluoride Chemicals Co., Ltd. (Hereinafter called "DFD"), etc.; total capacity of aluminum fluoride attained to 1.3 million tons, major manufacturers are Hunan Nonferrous Fluoride Chemical Group (HNFG), DFD, CNMC (Ningxia) Orient Group Limit Company, etc..

In China, electric grade fluoride is currently at its early stage of development, mostly represented by lithium hexafluorophosphate (LiPF6), whose capacity in 2011 experiencing a year-on-year increase of 123.0% to 2,720 tons, inclusive of 1,620 tons contributed by Morita Chemical Industries Co., Ltd. in China, accounting for 59.6%. However, LiPF6 capacities of DFD, Tianjin Jinniu Power Sources Material Co., Ltd., Jiangsu Jiujiujiu Technology Co., Ltd. are seeing rapid growth, and will climb to 2,200 tons, 2,000 tons and 2,000 tons in 2013, respectively. 

Organic fluoride sub-industry is chiefly compromised of fluorine refrigerant, fluorine-containing polymer (fluoropolymer), and so on. 

To know more about this reports, please visit @ China Fluorine Chemical Industry 

In China, fluorine refrigerants mainly refer to R22, R134a, R125 and R32, whose aggregate capacity in 2011 up to 964,000 tons, of which, R22 is the most widely used type for the present, but due to its destruction of the ozone layer, a step-by-step elimination will be inevitable; R134a is primarily employed as the automotive air-conditioning refrigerant, and Zhejiang Juhua Co., Ltd. as the leading company makes capacity of 58kt/a; R32 and R125 have found wide application in production of R410a and other mixed refrigerants (significant alternatives of R22), key enterprises are Jiangsu Meilan Chemical Co., Ltd. with 16k/a R32 and Sinochem Lantian Co., Ltd. with 11kt/a R125. 

Among Chinese fluoropolymer products, only PTFE is relatively developed, others such as PVDF and fluororubber are in the initial stages of development. In 2011, Chinas PTFE capacity reached 97kt, major manufacturers include Dongyue Group Ltd.(with capacity of 30kt/a), Zhonghao Chenguang Research Institute of Chemical Industry (15kt/a) and Zhejiang Juhua Co., Ltd (13kt/a).

China Fluorine Chemical Industry Chain Report, 2012-2015 of Research In China mainly covers the followings:

• Supply/demand, consumption structure, import/export, price trend, etc. of fluorite industry;
• Capacity, consumption structure, import/export, price trend, etc. of fluorine refrigerant and fluoropolymer industries;
• Capacity, import/export, price trend, etc. of hydrofluoric acid and aluminum fluoride industries;
• Operation, fluorine chemical business, growth prediction, etc. of 11 fluorine chemical companies;
• Development goals, planning, demand forecasting, etc. of fluorine chemical industry during 2011-2015.

latest Report:

Research Report on China's Antifungal Drug Market, 2013-2017

Research Report on China's Antidepressant Market, 2013-2017

Contact: sales@researchmoz.us for further information.

China's Diabetes Drug Market, 2013-2017 By Researchmoz.us

ResearchMoz.us include new market research report "Research Report on China's Diabetes Drug Market, 2013-2017" to its huge collection of research reports.Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and the latter is caused by the actions of various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical toxins, psychological factors on body. In recent years, with the development of China's economy and improvement in people's living standards, the incidence and morbidity rates of diabetes also present the increasing trend year by year.

In China, with the aggravation of aging degree, improvement in living standards and increase in obese groups caused by unhealthy lifestyles, the prevention and treatment of diabetes are increasingly severe. Since China carried out the first survey on diabetes epidemiology in 1980, the morbidity rate of diabetes increases from less than 1% then to about 10% currently. Following tumors and cardiovascular diseases, diabetes becomes the third-largest chronic disease severely threatening people's health. In 1994, diabetics only accounted for 2.5% of the population in China. This figure increased to 5.5% in 2002 and 9.7% in 2008.

More information of this report@  China's Diabetes Drug Market

In China, the diabetes morbidity rate of people aged above 20 has reached over 9.7%, and the morbidity rate of pre-diabetes (impaired fasting glucose and impaired glucose tolerance) has reached 15.5%. In developed regions of China, diabetics in the rural population are far less than that in the urban population. However, the morbidity rate of pre-diabetes, i.e., impaired glucose regulation, in the rural population is higher than that in the urban population, whether in developed or economically-backward areas. In economically-developed regions, the diabetes morbidity rate of the urban population is 13.6%, and that of the rural population is 16.6%. In medium-developed regions, the diabetes morbidity rate of the urban population is 15.6%, and that of the rural population is 20%. This also shows that, with the development of economy and changes in lifestyles, the rural population are potential groups who are more likely to suffer from diabetes.

Drug treatment is the focus of the treatment of diabetes. In addition to a small part of patients with type II diabetes which can be controlled through diet therapy and exercise therapy, the rest all need drug treatment. Diabetes drugs include Chinese patent drugs and western drugs, of which the latter is in a dominant position, while the former is in an auxiliary position in the treatment of diabetes.

With the increase in diabetes morbidity rate, residents' income levels and medical levels, the market size of China's diabetes drugs rises year by year, which always presents a rapidly growing trend in recent years, reaching CNY 15.86 billion in 2011, with an increase of 18.2% YOY.

In China, insulin preparations are always leaders in diabetes drug market, and the market share grows year by year recently, reaching 37.75% in 2011, with promising market prospects. Acarbose ranked the second. Before 2010, the share declined year after year, which slightly rebounded in 2011. Market shares of other varieties are all very low, which cannot threaten the market positions of insulin preparations and Acarbose.

The market size of China's diabetes drugs is expected to maintain an annual growth rate of over 18% from 2013 to 2017.

More following information can be acquired through this report:

Incidence of Diabetes in China

Market Situation of China's Hospital-use Diabetes Drugs

Competition in China's Diabetes Drug Market

Development Trends of Diabetes Treatment Technologies and Market in China 

Following people are recommended to buy this report:

Diabetes Drug Manufacturers

Pharmaceutical Trade Enterprises and Hospitals

Investors/Research Institutions Focusing on Diabetes Drugs

latest Report:

Research Report on China's Antifungal Drug Market, 2013-2017

Research Report on China's Antidepressant Market, 2013-2017

Contact: sales@researchmoz.us for further information.